| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Senior VP and General Counsel
1 company
Cynthia J Ladd last filed a Form 4 in January 2017, as Senior VP and General Counsel at CTMX. Cynthia J Ladd's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 3,000 shares of CTMX. Net of sales, the CTMX filings show accumulation of 3,000 shares.
Cynthia J Ladd has 3 Form 4 filings on record from July 2015 to January 2017, all as Senior VP and General Counsel at CytomX Therapeutics (CTMX), 2015–2017.
The 5 reported transactions were 4 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $36K and no sales.
The only open-market purchase was 3,000 shares of CTMX at an average $12.00 on October 14, 2015, about $36K.
Shares as reported in the last Form 4 for each company; the most recent is from January 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2015 | CTMX Cytomx Therapeutics, Inc. | Senior VP and General Counsel | Buy | 3,000 | $12.00 | $36,000.00 | New |